APO Research
Talk to an analyst

APO RESEARCH · REPORT

Arterial Thrombosis Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Arterial Thrombosis Drug Industry Growth and Trends Forecast to 2032

22 December 202596 pages

Choose your research edition.

Industry ResearchArterial Thrombosis Drug Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Arterial Thrombosis Drug Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Arterial Thrombosis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Arterial Thrombosis Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Arterial Thrombosis Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Arterial Thrombosis Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Arterial Thrombosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Arterial Thrombosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Arterial Thrombosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Arterial Thrombosis Drug include Eisai, Sanofi, Johnson & Johnson, Bayer AG, Thromboserin Ltd, Bristol-Myers Squibb Company and Astellas Pharma Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Arterial Thrombosis Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Arterial Thrombosis Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Arterial Thrombosis Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Arterial Thrombosis Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Arterial Thrombosis Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Arterial Thrombosis Drug Market by Company

Eisai

Sanofi

Johnson & Johnson

Bayer AG

Thromboserin Ltd

Bristol-Myers Squibb Company

Astellas Pharma Inc.

Arterial Thrombosis Drug Segment by Type

AS-1468240

ASP-6537

BAY-1213790

BMS-65445

Others

Arterial Thrombosis Drug Segment by Application

Clinic

Hospital

Others

Arterial Thrombosis Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arterial Thrombosis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Arterial Thrombosis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arterial Thrombosis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Arterial Thrombosis Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Arterial Thrombosis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of AS-1468240 Table 2. Major Company of ASP-6537 Table 3. Major Company of BAY-1213790 Table 4. Major Company of BMS-65445 Table 5. Major Company of Others Table 6. Global Arterial Thrombosis Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Arterial Thrombosis Drug Sales by Type (2021-2026) & (k units) Table 8. Global Arterial Thrombosis Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Arterial Thrombosis Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Arterial Thrombosis Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Arterial Thrombosis Drug Price by Type (2021-2026) & (US$/unit) Table 12. Global Arterial Thrombosis Drug Sales by Type (2027-2032) & (k units) Table 13. Global Arterial Thrombosis Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Arterial Thrombosis Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Arterial Thrombosis Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Arterial Thrombosis Drug Price by Type (2027-2032) & (US$/unit) Table 17. North America Arterial Thrombosis Drug Sales by Type (2021-2026) & (k units) Table 18. North America Arterial Thrombosis Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Arterial Thrombosis Drug Sales by Type (2021-2026) & (k units) Table 20. Europe Arterial Thrombosis Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Arterial Thrombosis Drug Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Arterial Thrombosis Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Arterial Thrombosis Drug Sales by Type (2021-2026) & (k units) Table 24. Latin America Arterial Thrombosis Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Arterial Thrombosis Drug Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Arterial Thrombosis Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Arterial Thrombosis Drug Industry Trends Table 28. Arterial Thrombosis Drug Industry Drivers Table 29. Arterial Thrombosis Drug Industry Opportunities and Challenges Table 30. Arterial Thrombosis Drug Industry Restraints Table 31. Global Arterial Thrombosis Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Arterial Thrombosis Drug Revenue Market Share by Company (2021-2026) Table 33. Global Arterial Thrombosis Drug Sales by Company (2021-2026) & (k units) Table 34. Global Arterial Thrombosis Drug Sales Share by Company (2021-2026) Table 35. Global Arterial Thrombosis Drug Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Arterial Thrombosis Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Arterial Thrombosis Drug Major Company Production Sites and Headquarters Table 38. Global Arterial Thrombosis Drug Company, Product Type & Application Table 39. Global Arterial Thrombosis Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Arterial Thrombosis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Arterial Thrombosis Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Arterial Thrombosis Drug Sales by Region (2021-2026) & (k units) Table 44. Global Arterial Thrombosis Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Arterial Thrombosis Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Arterial Thrombosis Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Arterial Thrombosis Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Arterial Thrombosis Drug Sales by Region (2027-2032) & (k units) Table 49. Global Arterial Thrombosis Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Arterial Thrombosis Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Arterial Thrombosis Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Arterial Thrombosis Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Arterial Thrombosis Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Arterial Thrombosis Drug Sales by Application (2021-2026) & (k units) Table 55. Global Arterial Thrombosis Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Arterial Thrombosis Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Arterial Thrombosis Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Arterial Thrombosis Drug Price by Application (2021-2026) & (US$/unit) Table 59. Global Arterial Thrombosis Drug Sales by Application (2027-2032) & (k units) Table 60. Global Arterial Thrombosis Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Arterial Thrombosis Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Arterial Thrombosis Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Arterial Thrombosis Drug Price by Application (2027-2032) & (US$/unit) Table 64. North America Arterial Thrombosis Drug Sales by Application (2021-2026) & (k units) Table 65. North America Arterial Thrombosis Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Arterial Thrombosis Drug Sales by Application (2021-2026) & (k units) Table 67. Europe Arterial Thrombosis Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Arterial Thrombosis Drug Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Arterial Thrombosis Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Arterial Thrombosis Drug Sales by Application (2021-2026) & (k units) Table 71. Latin America Arterial Thrombosis Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Arterial Thrombosis Drug Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Arterial Thrombosis Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Eisai Company Information Table 75. Eisai Business Overview Table 76. Eisai Arterial Thrombosis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Eisai Arterial Thrombosis Drug Product Portfolio Table 78. Eisai Recent Development Table 79. Sanofi Company Information Table 80. Sanofi Business Overview Table 81. Sanofi Arterial Thrombosis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Sanofi Arterial Thrombosis Drug Product Portfolio Table 83. Sanofi Recent Development Table 84. Johnson & Johnson Company Information Table 85. Johnson & Johnson Business Overview Table 86. Johnson & Johnson Arterial Thrombosis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Johnson & Johnson Arterial Thrombosis Drug Product Portfolio Table 88. Johnson & Johnson Recent Development Table 89. Bayer AG Company Information Table 90. Bayer AG Business Overview Table 91. Bayer AG Arterial Thrombosis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Bayer AG Arterial Thrombosis Drug Product Portfolio Table 93. Bayer AG Recent Development Table 94. Thromboserin Ltd Company Information Table 95. Thromboserin Ltd Business Overview Table 96. Thromboserin Ltd Arterial Thrombosis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Thromboserin Ltd Arterial Thrombosis Drug Product Portfolio Table 98. Thromboserin Ltd Recent Development Table 99. Bristol-Myers Squibb Company Company Information Table 100. Bristol-Myers Squibb Company Business Overview Table 101. Bristol-Myers Squibb Company Arterial Thrombosis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Bristol-Myers Squibb Company Arterial Thrombosis Drug Product Portfolio Table 103. Bristol-Myers Squibb Company Recent Development Table 104. Astellas Pharma Inc. Company Information Table 105. Astellas Pharma Inc. Business Overview Table 106. Astellas Pharma Inc. Arterial Thrombosis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Astellas Pharma Inc. Arterial Thrombosis Drug Product Portfolio Table 108. Astellas Pharma Inc. Recent Development Table 109. North America Arterial Thrombosis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 110. North America Arterial Thrombosis Drug Sales by Country (2021-2026) & (k units) Table 111. North America Arterial Thrombosis Drug Sales Market Share by Country (2021-2026) Table 112. North America Arterial Thrombosis Drug Sales Forecast by Country (2027-2032) & (k units) Table 113. North America Arterial Thrombosis Drug Sales Market Share Forecast by Country (2027-2032) Table 114. North America Arterial Thrombosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. North America Arterial Thrombosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 116. North America Arterial Thrombosis Drug Market Share by Country (2021-2026) Table 117. North America Arterial Thrombosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. North America Arterial Thrombosis Drug Market Share Forecast by Country (2027-2032) Table 119. Europe Arterial Thrombosis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 120. Europe Arterial Thrombosis Drug Sales by Country (2021-2026) & (k units) Table 121. Europe Arterial Thrombosis Drug Sales Market Share by Country (2021-2026) Table 122. Europe Arterial Thrombosis Drug Sales Forecast by Country (2027-2032) & (k units) Table 123. Europe Arterial Thrombosis Drug Sales Market Share Forecast by Country (2027-2032) Table 124. Europe Arterial Thrombosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Europe Arterial Thrombosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 126. Europe Arterial Thrombosis Drug Market Share by Country (2021-2026) Table 127. Europe Arterial Thrombosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Europe Arterial Thrombosis Drug Market Share Forecast by Country (2027-2032) Table 129. Asia-Pacific Arterial Thrombosis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 130. Asia-Pacific Arterial Thrombosis Drug Sales by Country (2021-2026) & (k units) Table 131. Asia-Pacific Arterial Thrombosis Drug Sales Market Share by Country (2021-2026) Table 132. Asia-Pacific Arterial Thrombosis Drug Sales Forecast by Country (2027-2032) & (k units) Table 133. Asia-Pacific Arterial Thrombosis Drug Sales Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Arterial Thrombosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Arterial Thrombosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 136. Asia-Pacific Arterial Thrombosis Drug Market Share by Country (2021-2026) Table 137. Asia-Pacific Arterial Thrombosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Asia-Pacific Arterial Thrombosis Drug Market Share Forecast by Country (2027-2032) Table 139. Latin America Arterial Thrombosis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 140. Latin America Arterial Thrombosis Drug Sales by Country (2021-2026) & (k units) Table 141. Latin America Arterial Thrombosis Drug Sales Market Share by Country (2021-2026) Table 142. Latin America Arterial Thrombosis Drug Sales Forecast by Country (2027-2032) & (k units) Table 143. Latin America Arterial Thrombosis Drug Sales Market Share Forecast by Country (2027-2032) Table 144. Latin America Arterial Thrombosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Latin America Arterial Thrombosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 146. Latin America Arterial Thrombosis Drug Market Share by Country (2021-2026) Table 147. Latin America Arterial Thrombosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Latin America Arterial Thrombosis Drug Market Share Forecast by Country (2027-2032) Table 149. Middle East and Africa Arterial Thrombosis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 150. Middle East and Africa Arterial Thrombosis Drug Sales by Country (2021-2026) & (k units) Table 151. Middle East and Africa Arterial Thrombosis Drug Sales Market Share by Country (2021-2026) Table 152. Middle East and Africa Arterial Thrombosis Drug Sales Forecast by Country (2027-2032) & (k units) Table 153. Middle East and Africa Arterial Thrombosis Drug Sales Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Arterial Thrombosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Arterial Thrombosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Arterial Thrombosis Drug Market Share by Country (2021-2026) Table 157. Middle East and Africa Arterial Thrombosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Middle East and Africa Arterial Thrombosis Drug Market Share Forecast by Country (2027-2032) Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Arterial Thrombosis Drug Distributors List Table 162. Arterial Thrombosis Drug Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Arterial Thrombosis Drug Image Figure 2. Global Arterial Thrombosis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Arterial Thrombosis Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Arterial Thrombosis Drug Sales (2021-2032) & (k units) Figure 5. AS-1468240 Image Figure 6. Global AS-1468240 Sales YoY Growth (2021-2032) & (k units) Figure 7. ASP-6537 Image Figure 8. Global ASP-6537 Sales YoY Growth (2021-2032) & (k units) Figure 9. BAY-1213790 Image Figure 10. Global BAY-1213790 Sales YoY Growth (2021-2032) & (k units) Figure 11. BMS-65445 Image Figure 12. Global BMS-65445 Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Arterial Thrombosis Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Arterial Thrombosis Drug Market Share by Type 2025 VS 2032 Figure 17. North America Arterial Thrombosis Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Arterial Thrombosis Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Arterial Thrombosis Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Arterial Thrombosis Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Arterial Thrombosis Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Arterial Thrombosis Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Arterial Thrombosis Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Arterial Thrombosis Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Arterial Thrombosis Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Arterial Thrombosis Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Arterial Thrombosis Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Arterial Thrombosis Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Arterial Thrombosis Drug Market Share by Application 2025 VS 2032 Figure 37. North America Arterial Thrombosis Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Arterial Thrombosis Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Arterial Thrombosis Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Arterial Thrombosis Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Arterial Thrombosis Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Arterial Thrombosis Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Arterial Thrombosis Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Arterial Thrombosis Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Arterial Thrombosis Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Arterial Thrombosis Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Arterial Thrombosis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Arterial Thrombosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Arterial Thrombosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Arterial Thrombosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Arterial Thrombosis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Arterial Thrombosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Arterial Thrombosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Arterial Thrombosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Arterial Thrombosis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Arterial Thrombosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Arterial Thrombosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Arterial Thrombosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Arterial Thrombosis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Arterial Thrombosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Arterial Thrombosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Arterial Thrombosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Arterial Thrombosis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Arterial Thrombosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Arterial Thrombosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Arterial Thrombosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Arterial Thrombosis Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Arterial Thrombosis Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • AS-1468240
  • ASP-6537
  • BAY-1213790
  • BMS-65445
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Eisai
  • Sanofi
  • Johnson & Johnson
  • Bayer AG
  • Thromboserin Ltd
  • Bristol-Myers Squibb Company
  • Astellas Pharma Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Arterial Thrombosis Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Arterial Thrombosis Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Arterial Thrombosis Drug Market by Type
  6. 1.3.1 AS-1468240
  7. 1.3.2 ASP-6537
  8. 1.3.3 BAY-1213790
  9. 1.3.4 BMS-65445
  10. 1.3.5 Others
  11. 1.4 Global Arterial Thrombosis Drug Market Size by Type
  12. 1.4.1 Global Arterial Thrombosis Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Arterial Thrombosis Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Arterial Thrombosis Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Arterial Thrombosis Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Arterial Thrombosis Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Arterial Thrombosis Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Arterial Thrombosis Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Arterial Thrombosis Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Arterial Thrombosis Drug Industry Trends
  2. 2.2 Arterial Thrombosis Drug Industry Drivers
  3. 2.3 Arterial Thrombosis Drug Industry Opportunities and Challenges
  4. 2.4 Arterial Thrombosis Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Arterial Thrombosis Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Arterial Thrombosis Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Arterial Thrombosis Drug Price (2021-2026)
  4. 3.4 Global Arterial Thrombosis Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Arterial Thrombosis Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Arterial Thrombosis Drug Company, Product Type & Application
  7. 3.7 Global Arterial Thrombosis Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Arterial Thrombosis Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Arterial Thrombosis Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Arterial Thrombosis Drug Tier 1, Tier 2, and Tier 3
4 Arterial Thrombosis Drug Regional Status and Outlook
  1. 4.1 Global Arterial Thrombosis Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Arterial Thrombosis Drug Historic Market Size by Region
  3. 4.2.1 Global Arterial Thrombosis Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Arterial Thrombosis Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Arterial Thrombosis Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Arterial Thrombosis Drug Forecasted Market Size by Region
  7. 4.3.1 Global Arterial Thrombosis Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Arterial Thrombosis Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Arterial Thrombosis Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Arterial Thrombosis Drug by Application
  1. 5.1 Arterial Thrombosis Drug Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Arterial Thrombosis Drug Market Size by Application
  6. 5.2.1 Global Arterial Thrombosis Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Arterial Thrombosis Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Arterial Thrombosis Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Arterial Thrombosis Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Arterial Thrombosis Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Arterial Thrombosis Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Arterial Thrombosis Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Arterial Thrombosis Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eisai
  2. 6.1.1 Eisai Company Information
  3. 6.1.2 Eisai Business Overview
  4. 6.1.3 Eisai Arterial Thrombosis Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eisai Arterial Thrombosis Drug Product Portfolio
  6. 6.1.5 Eisai Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Arterial Thrombosis Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Arterial Thrombosis Drug Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Arterial Thrombosis Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Arterial Thrombosis Drug Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Bayer AG
  20. 6.4.1 Bayer AG Company Information
  21. 6.4.2 Bayer AG Business Overview
  22. 6.4.3 Bayer AG Arterial Thrombosis Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer AG Arterial Thrombosis Drug Product Portfolio
  24. 6.4.5 Bayer AG Recent Developments
  25. 6.5 Thromboserin Ltd
  26. 6.5.1 Thromboserin Ltd Company Information
  27. 6.5.2 Thromboserin Ltd Business Overview
  28. 6.5.3 Thromboserin Ltd Arterial Thrombosis Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Thromboserin Ltd Arterial Thrombosis Drug Product Portfolio
  30. 6.5.5 Thromboserin Ltd Recent Developments
  31. 6.6 Bristol-Myers Squibb Company
  32. 6.6.1 Bristol-Myers Squibb Company Company Information
  33. 6.6.2 Bristol-Myers Squibb Company Business Overview
  34. 6.6.3 Bristol-Myers Squibb Company Arterial Thrombosis Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bristol-Myers Squibb Company Arterial Thrombosis Drug Product Portfolio
  36. 6.6.5 Bristol-Myers Squibb Company Recent Developments
  37. 6.7 Astellas Pharma Inc.
  38. 6.7.1 Astellas Pharma Inc. Company Information
  39. 6.7.2 Astellas Pharma Inc. Business Overview
  40. 6.7.3 Astellas Pharma Inc. Arterial Thrombosis Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Astellas Pharma Inc. Arterial Thrombosis Drug Product Portfolio
  42. 6.7.5 Astellas Pharma Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Arterial Thrombosis Drug Sales by Country
  2. 7.1.1 North America Arterial Thrombosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Arterial Thrombosis Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Arterial Thrombosis Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Arterial Thrombosis Drug Market Size by Country
  6. 7.2.1 North America Arterial Thrombosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Arterial Thrombosis Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Arterial Thrombosis Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Arterial Thrombosis Drug Sales by Country
  2. 8.1.1 Europe Arterial Thrombosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Arterial Thrombosis Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Arterial Thrombosis Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Arterial Thrombosis Drug Market Size by Country
  6. 8.2.1 Europe Arterial Thrombosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Arterial Thrombosis Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Arterial Thrombosis Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Arterial Thrombosis Drug Sales by Country
  2. 9.1.1 Asia-Pacific Arterial Thrombosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Arterial Thrombosis Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Arterial Thrombosis Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Arterial Thrombosis Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Arterial Thrombosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Arterial Thrombosis Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Arterial Thrombosis Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Arterial Thrombosis Drug Sales by Country
  2. 10.1.1 South America Arterial Thrombosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Arterial Thrombosis Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Arterial Thrombosis Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Arterial Thrombosis Drug Market Size by Country
  6. 10.2.1 South America Arterial Thrombosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Arterial Thrombosis Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Arterial Thrombosis Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Arterial Thrombosis Drug Sales by Country
  2. 11.1.1 Middle East and Africa Arterial Thrombosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Arterial Thrombosis Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Arterial Thrombosis Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Arterial Thrombosis Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Arterial Thrombosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Arterial Thrombosis Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Arterial Thrombosis Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Arterial Thrombosis Drug Value Chain Analysis
  2. 12.1.1 Arterial Thrombosis Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Arterial Thrombosis Drug Production Mode & Process
  7. 12.2 Arterial Thrombosis Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Arterial Thrombosis Drug Distributors
  10. 12.2.3 Arterial Thrombosis Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst